Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognosis in congestive heart failure

T S Rector1, J N Cohn

  • 1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455.

Annual Review of Medicine
|January 1, 1994
PubMed
Summary

Heart failure patients can be stratified by prognostic variables like ejection fraction. Vasodilators improve survival, with greater benefits in worsening prognoses, aiding risk-benefit assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.

Journal of human hypertension·2012
Same author

Rationale for angiotensin II receptor blocker therapy in chronic heart failure.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2007
Same author

Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.

Journal of human hypertension·2005
Same author

Angiotensin receptor blockers and clinical trials in heart failure.

European heart journal·2003
Same author

Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD).

Vascular medicine (London, England)·2002
Same author

Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

Congestive heart failure (Greenwich, Conn.)·2002

Area of Science:

  • Cardiology and clinical medicine.

Background:

  • Heart failure patient management relies on prognostic variables.
  • Ejection fraction and peak oxygen consumption are key indicators for risk stratification.

Purpose of the Study:

  • To evaluate the role of prognostic variables in heart failure risk stratification.
  • To assess the survival benefits of vasodilators across different heart failure stages.

Main Methods:

  • Utilizing prognostic variables (ejection fraction, peak oxygen consumption) to categorize patients.
  • Analyzing the impact of vasodilators on survival rates.

Main Results:

  • Vasodilators demonstrate survival benefits in all heart failure stages.
  • The probability of benefit from vasodilators increases as the patient's prognosis worsens.

Conclusions:

  • Quantitative survival estimates are crucial for informed benefit-risk assessments in heart failure.
  • Prognostic variables and treatment effects should guide clinical decision-making.

Related Experiment Videos